Increased apelin following bone marrow mononuclear cell transplantation contributes to the improvement of cardiac function in patients with severe heart failure

Cell Transplantation

Volumn 18, Issue 12, 2009, Pages 1311-1318

  Gao, Lian Ru ^a   Xu, Ru Yi ^b   Zhang, Ning Kun ^a   Chen, Yu ^a   Wang, Zhi Guo ^a   Zhu, Zhi Ming ^a   Fei, Yu Xing ^a   Cao, Yi ^a   Xu, Hong Tao ^a   Yang, Ye ^a  

^a NAVY GENERAL HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Apelin; Cell transplantation; Heart failure; Paracrine

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; APELIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; BONE MARROW TRANSPLANTATION; CARDIAC PATIENT; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAM; ENZYME IMMUNOASSAY; FEMALE; HEART FAILURE; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PARACRINE SIGNALING; PATIENT DECISION MAKING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; BONE MARROW TRANSPLANTATION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART FUNCTION TESTS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN;

EID: 77349088310     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368909X474843     Document Type: Article

References (29)

1. Anversa, P.; Nadal-Ginard, B. Myocyte renewal and ventricular remodelling. Nature 415:240-243; 2002.
2. Assmus, B.; Honold, J.; Schachinger, V.; Britten, M. B.; Fischer-Rasokat, U.; Lehmann, R. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355:1210-1221; 2006.
3. Berry, M. F.; Pirolli, T. J.; Jayasankar, V.; Burdick, J.; Morine, K. J.; Gardner, T. J.; Woo, Y. J. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 110:II187-193; 2004.
4. Caplan, A. I.; Dennis, J. E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98:1076-1084; 2006.
5. Chong, K. S.; Gardner, R. S.; Morton, J. J.; Ashley, E. A.; Mcdonagh, T. A. Plasma concentration of the novel peptide apelin are decreased in patients with chronic heart failure. Eur. J. Heart Fail. 8:355-360; 2006.
6. Daia, T.; Ramirez-Correab, G.; Gaoa, W. D. Apelin increases contractility in failing cardiac muscle. Eur. J. Pharmacol. 553:222-228; 2006.
7. Foldes, G.; Horkay, F.; Szokodi, I.; Vuolteenaho, O.; Ilves, M.; Lindstedt, K. A.; Mayranpaa, M.; Sarman, B.; Seres, L.; Skoumal, R.; Lako-Futo, Z.; deChatel, R.; Ruskoaho, H.; Toth, M. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem. Biophys. Res. Commun. 308:480-485; 2003.
8. Gao, L. R.; Wang, Z. G.; Zhu, Z. M.; Yu, X. F.; Sheng, H. H.; Tao, T.; Zhang, N. K.; Chen, Y.; Xu, H. T.; Yang, Y. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy. Am. J. Cardiol. 98:597-602; 2006.
9. Gruh, I.; Beilner, J.; Blomer, U.; Schmiedl, A.; Schmidt-Richter, I.; Kruse, M. L.; Haverich, A.; Martin, U. No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 113:1326-1334; 2006.
10. Jackson, K. A.; Majka, S. M.; Wang, H.; Pocius, J.; Hartley, C. J.; Majesky, M. W.; Entman, M. L.; Michael, L. H.; Hirschi, K. K.; Goodel, M. A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107:1395-1402; 2001.
11. Janssens, S.; Dubois, C.; Bogaert, J.; Theunissen, K.; Deroose, C.; Desmet, W.; Kalantzi, M.; Herbots, L.; Sinnaeve, P.; Dens, J.; Maertens, J.; Rademakers, F.; Dymarkowski, S.; Gheysens, O.; Van Cleemput, J.; Bormans, G.; Nuyts, J.; Belmans, A.; Mortelmans, L.; Boogaerts, M.; Van de Werf, F. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367:113-121; 2006.
12. Jia, Y. X. Apelin protects myocardial injury induced by isoproterenol in rats. Regul. Pept. 133(N1-3):147-154; 2006.
13. Kevin, J. P. A.; George, P. M.; Corinna, M. L.; Mark, F. P.; Vivian, M. B.; Jeffrey, E. H.; Cohen, W. H.; Woo, Y. J. Ischemic heart failure enhances endogenous Myocardial apelin and APJ receptor expression. Cell. Mol. Biol. 12:127-138; 2007.
14. Kleinz, M. J.; Davenport, A. P. Emerging roles of apelin in biology and medicine. Pharmacol. Ther. 107:198-211; 2005.
15. Kocher, A. A.; Schuster, M. D.; Szabolcs, M. J.; Takuma, S.; Burkhoff, D.; Wang, J.; Homma, S.; Edwards, N. M.; Itescu, S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7:430-436; 2001.
16. Meyer, G. P.; Wollert, K. C.; Lotz, J.; Steffens, J.; Lippolt, P.; Fichtner, S.; Hecker, H.; Schaefer, A.; Arseniev, L.; Hertenstein, B.; Ganser, A.; Drexler, H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months? follow-up data from the randomized, controlled BOOST (bone marrow transfer to enhance ST elevation infarct regeneration) trial. Circulation 113: 1287-1294; 2006.
17. Nygren, J. M.; Jovinge, S.; Breibach, M.; Sawen, P.; Roll, W.; Hescheler, J.; Teneera, J.; Felshmann, B. K.; Jacobsen, S. E. Bone marrow-derived hematopoietic cell s generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10:494-501; 2004.
18. Orlic, D.; Kajstura, J.; Chimenti, S.; Jakoniuk, I.; Anderson, S. M.; Li, B.; Pickel, J.; Mckay, R.; Nada-Ginard, B.; Bodine, D. M.; Leri, A.; Anversa, P. Bone marrow cells regenerate infracted myocardium. Nature 420:701-705; 2001.
19. Ramos, G. A.; Hare, J. M. Cardiac cell-based therapy: Cell types and mechanisms of actions. Cell Transplant. 16:951-961; 2007.
20. Roland, E.; Kälin, A.; Martin, P.; Kretz, A.; Andrea, M.; Meyer, A.; Kispert, A.; Frank, L.; Heppner, F. L.; Brändli, A. W. Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. Dev. Biol. 305:599-614; 2007.
21. Ronkainen, V. P.; Ronkainen, J. J.; Hänninen, S. L.; Leskinen, H.; Ruas, J. L.; Pereira, T.; Poellinger, L.; Vuolteenaho, O.; Tavi, P. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J. 21:1821-1830; 2007.
22. Scott, I. C.; D'Amico, L. A.; Jin, S. W.; Jungblut, B.; Wehman, A. M.; Baier, H.; Audigier, Y.; Stainier, D. Y. R. The G protein-coupled receptor Agtrl1b regulates early development of myocardial rrogenitors. Dev. Cell 12: 403-413; 2007.
23. Siu Kwan Sze, S. K.; Dominique, P. V.; De Kleijn, L. R. C.; Tan, E. K. W.; Zhao, H.; Yeo, K. S.; Low, T. Y.; Lian, Q.; Lee, C. N.; Mitchell, W.; Oakley, R. M. E.; Lim, S. K. Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol. Cell. Proteomics 6:1680-1689; 2007.
24. Solomon, S. D.; Zelenkofske, S.; NcMurray, J. J. V.; Finn, P. V.; Velazquez, E.; Ertl, G.; Harsanyi, A.; Rouleau, L. J.; Maggioni, A.; Kober, L.; White, H.; Van de Werf, F.; Pieper, K.; Califf, R. M.; Pfeffer, M. A. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N. Engl. J. Med. 352: 2581-2588; 2005.
25. Szokodi, I.; Tavi, P.; Földes, G.; Voutilainen-Myllylä, S.; Ilves, M.; Tokola, H.; Pikkarainen, S.; Piuhola, J.; Rysä, J.; Töth, M.; Ruskoaho, H. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ. Res. 91:434-440; 2002.
26. Tatemoto, K.; Hosoya, M.; Habata, Y.; Fujii, R.; Kakegawa, T.; Zou, M. X.; Kawamata, Y.; Fukusumi, S.; Hinuma, S.; Kitada, C.; Kurokawa, T.; Onda, H.; Fujino, M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 251:471-476; 1998.
27. Xu, M. F.; Uemura, R.; Dai, Y.; Wang, Y. G.; Ashraf, M. In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J. Mol. Cell. Cardiol. 42: 441-448; 2007.
28. Zeng, X. X.; Wilm, T. P.; Sepich, D. S.; Solnica-Krezel, L. Apelin and its receptor control heart field formation during zebrafish gastrulation. Dev. Cell 12:391-402; 2007.
29. Ziegelhoeffer, T.; Fernandez, B.; Kostin, S.; Heil, M.; Voswinckel, R.; Helisch, A.; Schaper, W. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 94:230-238; 2004.